Montelukast added to inhaled beclomethasone in treatment of asthma

American Journal of Respiratory and Critical Care Medicine

Volumn 160, Issue 6, 1999, Pages 1862-1868

  Laviolette, Michel ^a,b,c,d   Malmstrom, Kerstin ^a,b,c,d   Lu, Susan ^a,b,c,d   Chervinsky, Paul ^a,b,c,d   Pujet, Jean Claude ^a,b,c,d   Peszek, Izabella ^a,b,c,d   Zhang, Ji ^a,b,c,d   Reiss, Theodore F ^a,b,c,d  

^a LAVAL UNIVERSITY   (Canada)

^b MERCK RESEARCH LABORATORIES   (United States)

^c New England Research Center Inc   (United States)

^d Ctr de Diagn et de Readaptation R   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE; BECLOMETASONE DIPROPIONATE; MONTELUKAST;

ARTICLE; ASTHENIA; ASTHMA; CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; DRUG MECHANISM; FEMALE; FORCED EXPIRATORY VOLUME; HEADACHE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; MALE; MULTICENTER STUDY; NAUSEA; NORMAL HUMAN; PRIORITY JOURNAL; SINGLE BLIND PROCEDURE; SINUSITIS; STEROID THERAPY; UPPER RESPIRATORY TRACT INFECTION;

EID: 0033405946     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.160.6.9803042     Document Type: Article

References (30)

1. National Asthma Education and Prevention Program. 1997. Expert Panel Report II: Guidelines for the Diagnosis, and Management of Asthma. U.S. Department of Health and Human Services, National Institute of Health, Bethesda, MD.
2. Woolcock, A., B. Lundback, N. Ringdal, and L. A. Jacques. 1996. Comparison of additional of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids. Am. J. Respir. Crit. Care Med. 153: 1481-1488.
3. Kelloway, J. S., R. A. Wyatt, and S. K. Adlis. 1994. Comparison of patients' compliance with prescribed oral and inhaled asthma medications. Arch. Intern. Med. 154:1349-1352.
4. Jones, T. R., M. Labelle, M. Belley, E. Champion, L. Charette, J. Evans, A. W. Ford-Hutchinson, J. Y. Gauthier, A. Lord, P. Masson, M. McAuliffe, C. S. McFarlane, K. M. Metters, C. Pickett, H. Piechuta, I. W. Rodger, N. Sawywe, R. N. Young, R. Zamboni, and W. M. Abraham. 1995. Pharmacology of montelukast sodium (Singulair), a potent and selective leukotriene D4 receptor antagonist. Can. J. Physiol. Pharmacol. 73:191-201.
5. Altman, L. C., Z. Munk, J. Seltzer, N. Noonan, S. Shingo, J. Zhang, and T. F. Reiss for the Montelukast Asthma Study Group. 1998. A placebo-controlled, dose-ranging study of montelukast, a cysteinyl leukotriene-receptor antagonist. J. Allergy Clin. Immunol. 102:50-56.
6. Noonan, M. J., P. Chervinsky, M. Brandon, J. Zhang, S. Kundu, J. McBurney, and T. F. Reiss for the Montelukast Asthma Study Group. 1998. Montelukast, a potent leukotriene receptor antagonist, causes dose-related improvements in chronic asthma. Eur. Respir. J. 11:1232-1239.
7. Reiss, T. F., C. A. Sorkness, W. Stricker, A. Botto, W. W. Busse, S. Kundu, and J. Zhang. 1997. Effects of montelukast (MK-0476), a potent cysteinyl leukotriene receptor antagonist, on bronchodilation in asthmatic subjects treated with and without inhaled corticosteroids. Thorax. 52:45-48.
8. 4) receptor antagonist, in patients with chronic asthma. J. Allergy Clin. Immunol. 98:528-534.
9. Botto, A., K. Malmstrom, S. Lu, J. Zhang, and T. F. Reiss. 1997. Centralized spirometry quality control lowers the variability in multicenter asthma clinical trials (abstract). Am. J. Respir. Crit. Care Med. 155:A893.
10. Santanello, N. C., B. L. Barber, T. F. Reiss, B. S. Friedman, E. F. Juniper, and J. Zhang. 1997. Measurement characteristics of two asthma symptom diary scales for use in clinical trials. Eur. Respir. J. 10:646-651.
11. Juniper, E. F., G. H. Guyatt, R. S. Epstein, P. J. Ferrie, R. Jaeschke, and T. K. Hiller. 1992. Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax 47:76-83.
12. Guillemin, F., C. Bombardier, and D. Beaton. 1993. Cross-cultural adaptation of health related quality of life measures: literature review and propose guidelines. J. Clin. Epidemiol. 46:1417-1432.
13. Zhang, J., C. Song, and T. F. Reiss. 1997. Development and validation of a sensitive measure of worsening asthma (abstract). Am. J. Respir. Crit. Care Med. 155:A892.
14. Dunnett, C. W., and A. C. Tamhane. 1992. Comparisons between a new drug and active and placebo controls in an efficacy clinical trial. Stat. Med. 11:1057-1063.
15. Pocock, S. J., N. L. Geller, and A. A. Tsiatis. 1987. The analysis of multipie endpoints in clinical trials. Biometrics 43:487-498.
16. Dworski, R., G. A. Fitzgerald, J. A. Oates, and J. R. Sheller. 1994. Effect of oral prednisone on airway inflammatory mediators in atopic asthma. Am. J. Respir. Crit. Care Med. 149:953-959.
17. Löfdahl, C. G., T. F. Reiss, J. A. Leff, E. Israel, M. J. Noonan, A. F. Finn, B. C. Seidenberg, T. Capizzi, S. Kundu, and P. Godard. 1999. A leukotriene receptor antagonist, montelukast, allows tapering of inhaled corticosteriods while maintaining asthma control: a randomized, placebo controlled trial. B.M.J. 319:1-4.
18. Tamaoki, J., M. Kondo, N. Sakai, J. Nakata, H. Takemura, A. Nagai, T. Takizawa, and K. Konno. 1997. Leukotriene antagonist prevents exacerbation of asthma during reduction of high-dose inhaled corticosteroid: the Tokyo Joshi-Idai Asthma Research Group. Am. J. Respir. Crit. Care Med. 155:1235-1240.
19. Bousquet, J., P. Chanez, A. M. Vignola, J.-Y. Lacoste, and F. B. Michel. 1994. Eosinophil inflammation in asthma. Am. J. Respir. Crit. Care Med. 150:933-938.
20. Reiss, T. F., P. Chervinsky, R. J. Dockhorn, S. Shingo, B. Seidenberg, and T. B. Edwards for the Montelukast Clinical Research Study Group. 1998. Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Arch. Intern. Med. 158:1213-1220.
21. Wempe, J. B., E. P. Tammeling, G. H. Koëter, L. Håkansson, P. Venge, and D. S. Postma. 1992. Blood eosinophil numbers and activity during 24 hours: effects of treatment with budesonide and bambuterol. J. Allergy Clin. Immunol. 90:757-765.
22. Pizzichini, E., J. A. Leff, T. F. Reiss, L. Hendeles, L. P. Boulet, L. X. Wei, A. Efthimiadis, J. Zhang, and F. E. Hargreave. 1999. Montelukast reduces airway eosinophilic inflammation in asthma: a randomized, controlled trial. Eur. Respir. J. (In press)
23. Djukanovic, R., S. Homeyard, C. Gratziou, J. Madden, A. Walls, S. Montefort, D. Peroni, R. Polosa, S. Holgate, and P. Howarth. 1997. The effect of treatment with oral corticosteroids on asthma symptoms and airway inflammation. Am. J. Respir. Crit. Care Med. 155:826-832.
24. Fuller, R., M. Johnson, and A. Bye. 1995. Fluticasone propionate - an update on preclinical and clinical experience. Respir. Med. 89:3-18.
25. Wickremasinghe, R. G., M. A. Kahn, and A. V. Hoffbrand. 1993. Do leukotrienes play a role in the regulation of proliferation of normal and leukemic hemopoietic cells? Prostaglandins Leukotr. Essent. Fatty Acids 48:123-126.
26. Greening, A. P., P. W. Ind, M. Northfield, and G. Shaw. 1995. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Lancet 344:219-224.
27. Pauwels, R. A., C.-G. Löfdahl, D. S. Postma, A. E. Tattersfield, P. O'Byrne, P. J. Barnes, and A. Ullman, for the Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. 1997. Effect of inhaled formoterol and budesonide on exacerbations of asthma. N. Engl. J. Med. 337:1405-1411.
28. Rivington, R. N., L. P. Boulet, J. Cote, H. Kreisman, D. I. Small, M. Alexander, A. Day, Z. Harsanyi, and A. C. Darke. 1995. Efficacy of Uniphyl, salbutamol, and their combination in asthmatic patients on high-dose inhaled steroids. Am. J. Respir. Crit. Care Med. 151:325-332.
29. Evans, D. J., D. A. Taylor, O. Zetterstrom, K. F. Chung, B. J. O'Connor, and P. J. Barnes. 1997. A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma. N. Engl. J. Med. 337:1412-1418.
30. Kamada, A. K., S. J. Szefler, R. J. Martin, H. A. Boushey, V. M. Chinchilli, J. M. Drazen, J. E. Fish, E. Israel, S. C. Lazarus, and R. F. Lemanske. 1996. Issues in the use of inhaled glucocorticoids. Am. J. Respir. Crit. Care Med. 153:1739-1748.